# Prophylactic Penehyclidine Hydrochloride Inhalation and 3-year Outcome After Surgery

> **NCT03868709** · PHASE4 · COMPLETED · sponsor: **Peking University First Hospital** · enrollment: 864 (actual)

## Conditions studied

- Postoperative Complications
- Long-term Outcome

## Interventions

- **DRUG:** Penehyclidine inhalation
- **DRUG:** Placebo inhalation

## Key facts

- **NCT ID:** NCT03868709
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-12
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 864 (ACTUAL)
- **Last updated:** 2025-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03868709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03868709, "Prophylactic Penehyclidine Hydrochloride Inhalation and 3-year Outcome After Surgery". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT03868709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*